BIOLASE, Inc.
BIOLQ
$0.0078
$0.00034.00%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.10% | 14.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.10% | 14.06% | |||
| Cost of Revenue | -6.88% | 2.22% | |||
| Gross Profit | -4.93% | 38.16% | |||
| SG&A Expenses | -38.44% | 2.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.86% | 0.81% | |||
| Operating Income | 78.42% | 28.86% | |||
| Income Before Tax | 49.03% | 57.04% | |||
| Income Tax Expenses | -40.00% | 5.26% | |||
| Earnings from Continuing Operations | 48.96% | 56.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 48.96% | 56.85% | |||
| EBIT | 78.42% | 28.86% | |||
| EBITDA | 98.05% | 33.52% | |||
| EPS Basic | 55.13% | 76.95% | |||
| Normalized Basic EPS | 52.88% | 77.04% | |||
| EPS Diluted | 55.13% | 76.95% | |||
| Normalized Diluted EPS | 52.88% | 77.04% | |||
| Average Basic Shares Outstanding | 8.06% | 87.15% | |||
| Average Diluted Shares Outstanding | 8.06% | 87.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
